TP53 and carcinoma: Among clear cell tumors 11 (69%) out of the 16 carcinomas were belonging to the subgroup of concomitant positivity for p21 and negativity for p53 compared with the remaining five (31%) clear tumors in the study where other combinations of p21 p53 status were presented.